Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 20;19(1):128.
doi: 10.1186/s12957-021-02242-1.

Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study

Yuan Peng  1 , Miao Liu  1 , Xianan Li  2 , Fuzhong Tong  1 , Yingming Cao  1 , Peng Liu  1 , Bo Zhou  1 , Hongjun Liu  1 , Lin Cheng  1 , Jiajia Guo  1 , Fei Xie  1 , Houpu Yang  1 , Siyuan Wang  1 , Chaobin Wang  1 , Yalin Chen  2 , Shu Wang  3
Affiliations

Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study

Yuan Peng et al. World J Surg Oncol. .

Abstract

Background: Although the ACOSOG Z0011 study showed that axillary lymph node dissection (ALND) could be avoided in a specific population of sentinel lymph node-positive patients, it is not widely accepted by Chinese surgeons. We conducted a prospective single-arm study to confirm whether or not the results of Z0011 are applicable to Chinese patients.

Methods: Patients conforming to the Z0011 criteria were prospectively enrolled at the Peking University People's Hospital Breast Center from November 2014 to June 2019. The clinicopathological features of the study group were compared with those of the Z0011 study group. Lymphedema after surgery, the incidence of local-regional recurrence, and survival were analyzed.

Results: One hundred forty-two patients who met the Z0011 eligibility criteria were enrolled in this study; 115 underwent sentinel lymph node biopsy (SLNB) alone. Compared with the Z0011 trial, younger patients were included (median age, 52 [26-82] years vs 54 [25-90] years; P = 0.03). For clinical T stage, tumor histology, hormone status, lymphovascular invasion, and the number of positive sentinel lymph nodes (SLNs), no statistically significant differences were observed. More patients received adjuvant chemotherapy and endocrine therapy in this study (90.85% vs 58.0% and 80.99% vs 46.6% respectively, P <0.001). A similar percentage of patients received radiotherapy, but more nodal radiotherapy procedures were carried out in our study (54.5% vs 16.9%). After a median follow-up of 29 months, only 1 patient (0.9%) had ipsilateral breast tumor recurrence, and no regional recurrence occurred.

Conclusion: Our study showed that it is achievable to avoid ALND in patients eligible for Z0011 in China.

Trial registration: ClinicalTrials.gov. Registration number NCT03606616 . Retrospectively registered on 31 July 2018.

Keywords: ACOSOG Z0011; Breast cancer; Chinese; Sentinel lymph node.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of the study procedures
Fig. 2
Fig. 2
Radiotherapy field in the prospective studies
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–575. doi: 10.1001/jama.2011.90. - DOI - PMC - PubMed
    1. Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918–926. doi: 10.1001/jama.2017.11470. - DOI - PMC - PubMed
    1. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast, version 1.2012. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 30 Jun 2017. 3.
    1. Dengel LT, et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast conserving therapy. Ann Surg Oncol. 2014;21:22–27. doi: 10.1245/s10434-013-3200-6. - DOI - PMC - PubMed
    1. Delpech Y, et al. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study. Ann Surg Oncol. 2013;20:2556–2561. doi: 10.1245/s10434-013-2917-6. - DOI - PubMed

MeSH terms

Associated data